These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

81 related items for PubMed ID: 7202984

  • 1. [Ancillary chemotherapy with trofosfamid, methotrexate and fluoro-uracil in cancer of the breast (author's transl)].
    Albrecht M, Jepsen G, Trams G, Thomsen K.
    Geburtshilfe Frauenheilkd; 1981 Jan; 41(1):1-5. PubMed ID: 7202984
    [Abstract] [Full Text] [Related]

  • 2. Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study.
    Rivkin SE, Green SJ, Lew D, Costanzi JJ, Athens JW, Osborne CK, Vaughn CB, Martino S.
    Cancer; 2003 Jan 01; 97(1):21-9. PubMed ID: 12491501
    [Abstract] [Full Text] [Related]

  • 3. [The results of 5 years of ancillary chemotherapy of carcinoma of the breast (author's transl)].
    von Maillot K, Egger H, Gunselmann W.
    Geburtshilfe Frauenheilkd; 1981 Jul 01; 41(7):461-4. PubMed ID: 7021305
    [Abstract] [Full Text] [Related]

  • 4. Combination chemotherapy as an adjuvant treatment in operable breast cancer.
    Bonadonna G, Brusamolino E, Valagussa P, Rossi A, Brugnatelli L, Brambilla C, De Lena M, Tancini G, Bajetta E, Musumeci R, Veronesi U.
    N Engl J Med; 1976 Feb 19; 294(8):405-10. PubMed ID: 1246307
    [Abstract] [Full Text] [Related]

  • 5. [5 years' experiences with adjuvant chemotherapy in primary breast cancer].
    Albrecht M, Kleinkauf-Houken A, Trams G, Thomsen K.
    Geburtshilfe Frauenheilkd; 1984 Sep 19; 44(9):550-6. PubMed ID: 6567559
    [Abstract] [Full Text] [Related]

  • 6. A prospective study of concurrent cyclophosphamide/methotrexate/5-fluorouracil and reduced-dose radiotherapy in patients with early-stage breast carcinoma.
    Bellon JR, Shulman LN, Come SE, Li X, Gelman RS, Silver BJ, Harris JR, Recht A.
    Cancer; 2004 Apr 01; 100(7):1358-64. PubMed ID: 15042668
    [Abstract] [Full Text] [Related]

  • 7. Natural history of more than 20 years of node-positive primary breast carcinoma treated with cyclophosphamide, methotrexate, and fluorouracil-based adjuvant chemotherapy: a study by the Cancer and Leukemia Group B.
    Weiss RB, Woolf SH, Demakos E, Holland JF, Berry DA, Falkson G, Cirrincione CT, Robbins A, Bothun S, Henderson IC, Norton L, Cancer and Leukemia Group B.
    J Clin Oncol; 2003 May 01; 21(9):1825-35. PubMed ID: 12721260
    [Abstract] [Full Text] [Related]

  • 8. [Clinical analysis of resectable breast cancer: a report of 6 263 cases].
    Yang MT, Rong TH, Huang ZF, Zeng CG, Long H, Fu JH, Lin P, Wang X, Wang SY, Wang X, Tang J.
    Ai Zheng; 2005 Mar 01; 24(3):327-31. PubMed ID: 15757535
    [Abstract] [Full Text] [Related]

  • 9. [Adjuvant chemotherapy in breast cancer: status in 1984].
    Jungi WF.
    Wien Klin Wochenschr; 1984 Jun 22; 96(13):486-92. PubMed ID: 6382805
    [Abstract] [Full Text] [Related]

  • 10. Recurrence rates after DCE-MRI image guided planning for breast-conserving surgery following neoadjuvant chemotherapy for locally advanced breast cancer patients.
    Garimella V, Qutob O, Fox JN, Long ED, Chaturvedi A, Turnbull LW, Drew PJ.
    Eur J Surg Oncol; 2007 Mar 22; 33(2):157-61. PubMed ID: 17085007
    [Abstract] [Full Text] [Related]

  • 11. [Simultaneous radiochemotherapy in locoregional recurrent breast carcinoma after mastectomy. Results in patients with macroscopic residual tumor R2].
    Renner H, van Kampen M.
    Strahlenther Onkol; 1994 Aug 22; 170(8):441-52. PubMed ID: 8085210
    [Abstract] [Full Text] [Related]

  • 12. Surgery and adjuvant chemotherapy in the treatment of operable breast cancer.
    Rossi A, Valagussa P, Bonadonna G.
    Prog Clin Biol Res; 1977 Aug 22; 12():391-404. PubMed ID: 335401
    [No Abstract] [Full Text] [Related]

  • 13. A comparison of the outcomes of non-randomised chemotherapy regimens in node positive breast cancer.
    Kuru B, Camlibel M, Dinc S, Gulcelik MA, Atalay C, Alagol H.
    J Exp Clin Cancer Res; 2005 Sep 22; 24(3):363-72. PubMed ID: 16270522
    [Abstract] [Full Text] [Related]

  • 14. Identifying good prognosis group of breast cancer patients with 1-3 positive axillary nodes for adjuvant cyclophosphamide, methotrexate and 5-fluorouracil (CMF) chemotherapy.
    Lin YC, Chen SC, Chang HK, Hsueh S, Tsai CS, Lo YF, Hwang TL, Chen MF.
    Jpn J Clin Oncol; 2005 Sep 22; 35(9):514-9. PubMed ID: 16199422
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. One more change of paradigm in breast cancer treatment. Postmastectomy radiotherapy for patients with one to three lymph node metastases?
    Sautter-Bihl ML, Sauer R.
    Strahlenther Onkol; 2007 Jul 22; 183(7):357-9. PubMed ID: 17609867
    [No Abstract] [Full Text] [Related]

  • 17. Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancer.
    Gasparini G, Barbareschi M, Doglioni C, Palma PD, Mauri FA, Boracchi P, Bevilacqua P, Caffo O, Morelli L, Verderio P.
    Clin Cancer Res; 1995 Feb 22; 1(2):189-98. PubMed ID: 9815973
    [Abstract] [Full Text] [Related]

  • 18. Oral uracil and tegafur compared with classic cyclophosphamide, methotrexate, fluorouracil as postoperative chemotherapy in patients with node-negative, high-risk breast cancer: National Surgical Adjuvant Study for Breast Cancer 01 Trial.
    Watanabe T, Sano M, Takashima S, Kitaya T, Tokuda Y, Yoshimoto M, Kohno N, Nakagami K, Iwata H, Shimozuma K, Sonoo H, Tsuda H, Sakamoto G, Ohashi Y.
    J Clin Oncol; 2009 Mar 20; 27(9):1368-74. PubMed ID: 19204202
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Conventional adjuvant chemotherapy versus single-cycle, autograft-supported, high-dose, late-intensification chemotherapy in high-risk breast cancer patients: a randomized trial.
    Leonard RC, Lind M, Twelves C, Coleman R, van Belle S, Wilson C, Ledermann J, Kennedy I, Barrett-Lee P, Perren T, Verrill M, Cameron D, Foster E, Yellowlees A, Crown J, Anglo-Celtic Cooperative Oncology Group.
    J Natl Cancer Inst; 2004 Jul 21; 96(14):1076-83. PubMed ID: 15265969
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.